Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

MRNA - Moderna, Inc. Financial Statements | Finranks

Home

/

MRNA

M

Moderna, Inc. (MRNA)

NMS – Real Time Price. Currency in USD

64.07

+3.50 (5.78%)

Market open: Aug 12, 2026, 2:11 PM EDT

60.66

+0.09 (0.15%)

Previous after-hours: Aug 11, 2026, 7:57 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

1.94B

3.24B

6.84B

19.11B

Cost of goods sold

-1.08B

-1.65B

-5.31B

-5.76B

Gross Profit

861M

1.58B

1.53B

13.35B

Operating expenses (excl. COGS)

-3.94B

-5.53B

-5.77B

-4.08B

Operating Income

-3.07B

-3.94B

-4.25B

9.27B

Non-operating income, total

306M

338M

305M

309M

Pretax income

-2.77B

-3.61B

-3.94B

9.57B

Equity in earnings

-

0

-

-

Taxes

-54M

46M

-772M

-1.21B

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-2.82B

-3.56B

-4.71B

8.36B

Discontinued operations

0

0

0

0

Net income

-2.82B

-3.56B

-4.71B

8.36B

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

12.34B-12.8%

14.14B-23.2%

18.43B-29.4%

26.09B

Total current assets

6.54B

8.10B

10.32B

13.43B

Total non-current assets

5.79B

6.04B

8.10B

12.66B

Total liabilities

3.69B+13.8%

3.24B-29.1%

4.57B-34.3%

6.96B

Total current liabilities

1.99B

2.21B

3.02B

4.92B

Total non-current liabilities

1.70B

1.03B

1.56B

2.04B

Total equity

8.65B

10.90B

13.85B

19.12B

Total liabilities & shareholders' equities

12.34B

14.14B

18.43B

26.09B

Total debt

1.30B+74.7%

747M-39.9%

1.24B+3.6%

1.20B

Name

2025

2024

2023

2022

Cash from operating activities

-1.87B

-3B

-3.12B

4.98B

Cash from investing activities

1.95B

1.95B

4.21B

-5.18B

Cash from financing activities

593M

56M

-1.38B

-3.45B

Free cash flow

-2.06B+49.1%

-4.05B-6.0%

-3.83B-183.5%

4.58B